Company / Current Liabilities
ANAPTYSBIO, INC Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$38.6M
FY2025
5-year range
$16.1M / $45.4M
FY2021-FY2025
Trend
-15.0%
vs FY2024
Sector context
#161 of 213
Health Care
What the data says
ANAPTYSBIO, INC's current liabilities of $39M is lower than 76% of companies in the Health Care sector (FY2025). Current Liabilities has fluctuated over the past 10 years, ranging from $6M in FY2016 to $45M in FY2024.
Based on SEC 10-K filings.
$39M in FY2025 with a 5-year CAGR of +14.3%.
Increased from $37M to $39M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +14.0%
- 5-Year CAGR
- +14.3%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 213This company $38.6M Sector average $1.6B
▼
-97.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +14.3%, indicating consistent growth.
- In FY2025, current liabilities decreased 15.0% year-over-year.
- Ranks #161 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $38.6M | -15.0% |
| FY2024 | $45.4M | +21.3% |
| FY2023 | $37.4M | +43.7% |
| FY2022 | $26.1M | +61.8% |
| FY2021 | $16.1M | -18.8% |
| FY2020 | $19.8M | -32.9% |
| FY2019 | $29.5M | +35.3% |
| FY2018 | $21.8M | +55.0% |
| FY2017 | $14.1M | +146.8% |
| FY2016 | $5.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026